UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
Go back to UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6
September 27, 2022 12:25 PM EDT
Statera Biopharma (NASDAQ: STAB) Resumes Trading
...
More
September 27, 2022 9:14 AM EDT
Statera Biopharma (NASDAQ: STAB) Halted, News Pending
...
More